-
81.ACETYL MIMIC COMPOUNDS FOR THE INHIBITION OF ISOPRENYL-S-CYSTEINYL METHYLTRANSFERASE 审中-公开
标题翻译: 用于抑制异丙肾上腺素甲基衍生物的乙酰胆碱化合物公开(公告)号:US20110053901A1
公开(公告)日:2011-03-03
申请号:US12867796
申请日:2009-02-13
申请人: Seung-Yub Lee , Michael Voronkov , Peter Wolanin
发明人: Seung-Yub Lee , Michael Voronkov , Peter Wolanin
IPC分类号: A61K31/5375 , C07D211/72 , A61K31/44 , C07C279/02 , A61K31/22 , C07D257/04 , A61K31/41 , A61K31/155 , C07C257/00 , A61K31/18 , C07C311/01 , A61K31/4164 , C07D233/00 , C07C321/02 , A61K31/195 , C07D265/30 , A61K31/445 , C07D211/60 , C07D233/38 , C07D239/24 , A61K31/505 , A61K31/56 , A61K31/40
CPC分类号: C07D233/88 , C07C323/57 , C07C323/58 , C07C323/59 , C07C323/60 , C07C327/42 , C07C335/08 , C07D207/22 , C07D207/34 , C07D213/74 , C07D233/70 , C07D235/14 , C07D239/42 , C07D249/04 , C07D257/04 , C07D263/48 , C07D265/30 , C07D277/42 , C07D295/215 , C07D401/12 , C07D403/12 , C07D413/12 , C07D417/12
摘要: Among other things, the present invention provides novel compounds capable of effectively inhibiting inflammatory responses that are mediated by G-proteins or GPCRs in neutrophils, macrophages and platelets. In particular, compounds of the present invention act as inhibitors of edema, inhibitors of erythema and inhibitors of MPO (myeloperoxidase), pharmaceutical compositions containing the same compounds and the use thereof for the treatment of diseases that may benefit from edema, erythema and MPO inhibition, such as inflammation (acute or chronic), asthma, autoimmune diseases, and chronic obstructive pulmonary disease (COPD) (e.g., emphysema, chronic bronchitis and small airways disease, etc.), inflammatory responses of the immune system, skin diseases (e.g., reducing acute skin irritation for patients suffering from rosacea, atopic dermatitis, seborrheic dermatitis, psoriasis), irritable bowel syndrome (e.g., Chron's disease and ulcerative colitis, etc.), and central nervous system disorders (e.g., Parkinson's disease).
摘要翻译: 除此之外,本发明提供能够有效抑制嗜中性粒细胞,巨噬细胞和血小板中G蛋白或GPCR介导的炎症反应的新型化合物。 特别地,本发明的化合物作为水肿抑制剂,红斑抑制剂和MPO抑制剂(髓过氧化物酶),含有相同化合物的药物组合物及其用于治疗可能受益于水肿,红斑和MPO抑制的疾病的用途 例如炎症(急性或慢性),哮喘,自身免疫疾病和慢性阻塞性肺病(COPD)(例如肺气肿,慢性支气管炎和小气道疾病等),免疫系统的炎症反应,皮肤疾病(例如 对于患有酒渣鼻,特应性皮炎,脂溢性皮炎,牛皮癣的患者,肠易激综合征(例如,Chron氏病和溃疡性结肠炎等)以及中枢神经系统疾病(例如帕金森氏病))减少急性皮肤刺激。
-
公开(公告)号:US07504517B2
公开(公告)日:2009-03-17
申请号:US11765359
申请日:2007-06-19
申请人: John Michael Janusz , Stephen Joseph Hodson , Gregory Kent Bosch , Ronald Eugene White , Benjamin E. Blass , Christopher M. Jackson , Neil T. Fairweather
发明人: John Michael Janusz , Stephen Joseph Hodson , Gregory Kent Bosch , Ronald Eugene White , Benjamin E. Blass , Christopher M. Jackson , Neil T. Fairweather
IPC分类号: C07D233/38 , A61K31/4166
CPC分类号: C07D233/38
摘要: The present invention relates to 1-N-amino-2-imidazolidinones and derivatives thereof which are effective as Kv1.5 potassium channel inhibitors providing atrial-selective antiarrhythmic agents. The present invention further relates to compositions comprising said Kv1.5 potassium channel inhibitors, and to methods for treating cardiac arrhythmia.
摘要翻译: 本发明涉及作为提供心房选择性抗心律失常药物的Kv1.5钾通道抑制剂有效的1-N-氨基-2-咪唑啉酮及其衍生物。 本发明还涉及包含所述Kv1.5钾通道抑制剂的组合物,以及用于治疗心律失常的方法。
-
公开(公告)号:US20050272931A1
公开(公告)日:2005-12-08
申请号:US11099978
申请日:2005-04-05
申请人: Yunxin Bo , Partha Chakrabarti , Ning Chen , Elizabeth Doherty , Christopher Fotsch , Nianhe Han , Michael Kelly , Qingyian Liu , Mark Norman , Vassil Ognyanov , Xianghong Wang , Jiawang Zhu
发明人: Yunxin Bo , Partha Chakrabarti , Ning Chen , Elizabeth Doherty , Christopher Fotsch , Nianhe Han , Michael Kelly , Qingyian Liu , Mark Norman , Vassil Ognyanov , Xianghong Wang , Jiawang Zhu
IPC分类号: C07D249/18 , A61K31/17 , A61K31/18 , A61K31/343 , A61K31/357 , A61K31/36 , A61K31/37 , A61K31/381 , A61K31/4025 , A61K31/404 , A61K31/41 , A61K31/415 , A61K31/4184 , A61K31/4192 , A61K31/423 , A61K31/428 , A61K31/44 , A61K31/4402 , A61K31/4406 , A61K31/443 , A61K31/444 , A61K31/453 , A61K31/47 , A61K31/4704 , A61K31/4709 , A61K31/472 , A61K31/496 , A61K31/4965 , A61K31/498 , A61K31/505 , A61K31/517 , A61K31/5375 , A61K31/538 , A61P1/00 , A61P1/04 , A61P1/12 , A61P3/10 , A61P9/00 , A61P11/00 , A61P11/02 , A61P11/06 , A61P13/00 , A61P13/10 , A61P17/00 , A61P17/02 , A61P17/04 , A61P17/06 , A61P17/14 , A61P19/02 , A61P25/00 , A61P25/06 , A61P27/02 , A61P29/00 , A61P31/12 , A61P37/08 , A61P43/00 , C07C233/11 , C07C233/15 , C07C233/33 , C07C233/44 , C07C311/13 , C07C311/16 , C07C317/40 , C07C323/35 , C07D209/08 , C07D209/12 , C07D209/42 , C07D209/48 , C07D213/26 , C07D213/64 , C07D213/643 , C07D213/74 , C07D213/75 , C07D215/22 , C07D215/227 , C07D215/32 , C07D215/38 , C07D215/40 , C07D215/42 , C07D217/04 , C07D231/40 , C07D231/56 , C07D233/38 , C07D235/08 , C07D235/26 , C07D237/20 , C07D239/42 , C07D239/88 , C07D239/90 , C07D241/20 , C07D241/42 , C07D263/56 , C07D265/36 , C07D277/62 , C07D277/82 , C07D307/79 , C07D311/16 , C07D319/18 , C07D319/20 , C07D401/12 , C07D401/14 , C07D403/12 , C07D405/12 , C07D405/14 , C07D407/12 , C07D409/12 , C07D409/14 , C07D413/12 , C07D417/12 , C07D417/14 , C07D471/04 , C07D215/16
CPC分类号: C07D471/04 , C07D209/08 , C07D209/12 , C07D209/42 , C07D209/48 , C07D213/26 , C07D213/643 , C07D213/74 , C07D213/75 , C07D215/227 , C07D215/38 , C07D217/04 , C07D231/40 , C07D231/56 , C07D233/38 , C07D237/20 , C07D239/42 , C07D239/90 , C07D241/42 , C07D263/56 , C07D265/36 , C07D277/62 , C07D277/82 , C07D307/79 , C07D319/20 , C07D401/12 , C07D401/14 , C07D403/12 , C07D405/12 , C07D407/12 , C07D409/14 , C07D413/12 , C07D417/12 , C07D417/14
摘要: Compounds having the general structure and compositions containing them, for the treatment of acute, inflammatory and neuropathic pain, dental pain, general headache, migraine, cluster headache, mixed-vascular and non-vascular syndromes, tension headache, general inflammation, arthritis, rheumatic diseases, osteoarthritis, inflammatory bowel disorders, inflammatory eye disorders, inflammatory or unstable bladder disorders, psoriasis, skin complaints with inflammatory components, chronic inflammatory conditions, inflammatory pain and associated hyperalgesia and allodynia, neuropathic pain and associated hyperalgesia and allodynia, diabetic neuropathy pain, causalgia, sympathetically maintained pain, deafferentation syndromes, asthma, epithelial tissue damage or dysfunction, herpes simplex, disturbances of visceral motility at respiratory, genitourinary, gastrointestinal or vascular regions, wounds, burns, allergic skin reactions, pruritis, vitiligo, general gastrointestinal disorders, gastric ulceration, duodenal ulcers, diarrhea, gastric lesions induced by necrotising agents, hair growth, vasomotor or allergic rhinitis, bronchial disorders or bladder disorders.
-
公开(公告)号:US20050267163A1
公开(公告)日:2005-12-01
申请号:US11195302
申请日:2005-08-01
申请人: Elizabeth M. Doherty , Jiawang Zhu , Markian Stec , Mark H. Norman , Vassil I. Ognyanov , Christopher H. Fotsch , Ning Chen , Partha P. Chakrabarti , Liping H. Pettus , Hui-Ling Wang , Xianghong Wang , Premilla Arasasingham
发明人: Elizabeth M. Doherty , Jiawang Zhu , Markian Stec , Mark H. Norman , Vassil I. Ognyanov , Christopher H. Fotsch , Ning Chen , Partha P. Chakrabarti , Liping H. Pettus , Hui-Ling Wang , Xianghong Wang , Premilla Arasasingham
IPC分类号: A61K31/4709 , A61K31/501 , A61K31/505 , A61K31/506 , A61K31/5377 , A61P1/00 , A61P1/04 , A61P9/00 , A61P11/00 , A61P11/02 , A61P11/06 , A61P13/00 , A61P15/00 , A61P17/00 , A61P17/02 , A61P17/06 , A61P17/14 , A61P19/02 , A61P25/00 , A61P25/02 , A61P25/04 , A61P25/06 , A61P27/02 , A61P29/00 , A61P37/08 , C07D209/08 , C07D209/12 , C07D209/42 , C07D209/48 , C07D213/26 , C07D213/64 , C07D213/643 , C07D213/74 , C07D213/75 , C07D215/22 , C07D215/227 , C07D215/38 , C07D217/04 , C07D231/40 , C07D231/56 , C07D233/38 , C07D237/20 , C07D239/42 , C07D239/90 , C07D241/42 , C07D263/56 , C07D265/36 , C07D277/62 , C07D277/82 , C07D307/79 , C07D319/20 , C07D401/12 , C07D401/14 , C07D403/12 , C07D405/12 , C07D407/12 , C07D409/14 , C07D413/12 , C07D417/12 , C07D417/14 , C07D471/04 , A61K31/4439 , C07D413/02 , C07D417/02 , C07D43/02
CPC分类号: C07D231/40 , C07D209/08 , C07D209/12 , C07D209/42 , C07D209/48 , C07D213/26 , C07D213/643 , C07D213/74 , C07D213/75 , C07D215/227 , C07D215/38 , C07D217/04 , C07D231/56 , C07D233/38 , C07D237/20 , C07D239/42 , C07D239/90 , C07D241/42 , C07D263/56 , C07D265/36 , C07D277/62 , C07D277/82 , C07D307/79 , C07D319/20 , C07D401/12 , C07D401/14 , C07D403/12 , C07D405/12 , C07D407/12 , C07D409/14 , C07D413/12 , C07D417/12 , C07D417/14 , C07D471/04
摘要: Compounds having the general structure and compositions containing them, for the treatment of acute, inflammatory and neuropathic pain, dental pain, general headache, migraine, cluster headache, mixed-vascular and non-vascular syndromes, tension headache, general inflammation, arthritis, rheumatic diseases, osteoarthritis, inflammatory bowel disorders, inflammatory eye disorders, inflammatory or unstable bladder disorders, psoriasis, skin complaints with inflammatory components, chronic inflammatory conditions, inflammatory pain and associated hyperalgesia and allodynia, neuropathic pain and associated hyperalgesia and allodynia, diabetic neuropathy pain, causalgia, sympathetically maintained pain, deafferentation syndromes, asthma, epithelial tissue damage or dysfunction, herpes simplex, disturbances of visceral motility at respiratory, genitourinary, gastrointestinal or vascular regions, wounds, burns, allergic skin reactions, pruritis, vitiligo, general gastrointestinal disorders, gastric ulceration, duodenal ulcers, diarrhea, gastric lesions induced by necrotising agents, hair growth, vasomotor or allergic rhinitis, bronchial disorders or bladder disorders.
-
公开(公告)号:US20050234065A1
公开(公告)日:2005-10-20
申请号:US11102394
申请日:2005-04-08
申请人: Bernard Hulin , Janice Parker , David Piotrowski
发明人: Bernard Hulin , Janice Parker , David Piotrowski
IPC分类号: A61K31/498 , A61K31/519 , C07D207/08 , C07D207/10 , C07D207/12 , C07D207/16 , C07D207/28 , C07D209/46 , C07D213/82 , C07D231/38 , C07D233/38 , C07D241/24 , C07D241/26 , C07D263/16 , C07D263/18 , C07D263/24 , C07D263/44 , C07D275/06 , C07D295/185 , C07D401/12 , C07D403/12 , C07D417/08 , C07D417/12 , C07D471/02 , C07D471/04 , C07D487/04 , C07D491/02 , C07D493/04 , C07D495/04 , C07D498/02
CPC分类号: C07D207/10 , C07D207/08 , C07D207/12 , C07D207/16 , C07D207/28 , C07D209/46 , C07D213/82 , C07D231/38 , C07D233/38 , C07D241/24 , C07D241/26 , C07D263/16 , C07D263/18 , C07D263/24 , C07D263/44 , C07D275/06 , C07D295/185 , C07D401/12 , C07D403/12 , C07D417/08 , C07D417/12 , C07D471/04 , C07D487/04 , C07D493/04 , C07D495/04
摘要: The invention provides compounds of Formula (I) or prodrugs thereof, or pharmaceutically acceptable salts of said compounds or prodrugs, or solvates of said compounds, prodrugs or salts, wherein A, N, X and R1 are as defined herein; pharmaceutical compositions thereof; and methods of using the pharmaceutical compositions for the treatment of diseases, including Type 2 diabetes, Type 1 diabetes, impaired glucose tolerance, hyperglycemia, metabolic syndrome (syndrome X and/or insulin resistance syndrome), glucosuria, metabolic acidosis, arthritis, cataracts, diabetic neuropathy, diabetic nephropathy, diabetic retinopathy, diabetic cardiomyopathy, obesity, conditions exacerbated by obesity, hypertension, hyperlipidemia, atherosclerosis, osteoporosis, osteopenia, frailty, bone loss, bone fracture, acute coronary syndrome, short stature due to growth hormone deficiency, infertility due to polycystic ovary syndrome, anxiety, depression, insomnia, chronic fatigue, epilepsy, eating disorders, chronic pain, alcohol addiction, diseases associated with intestinal motility, ulcers, irritable bowel syndrome, inflammatory bowel syndrome; short bowel syndrome; and the prevention of disease progression in Type 2 diabetes.
摘要翻译: 本发明提供式(I)化合物或其前药,或所述化合物或前药的药学上可接受的盐,或所述化合物,前药或盐的溶剂合物,其中A,N,X和R 1是 如本文所定义; 其药物组合物; 以及使用该药物组合物治疗疾病的方法,包括2型糖尿病,1型糖尿病,葡萄糖耐量降低,高血糖症,代谢综合征(X综合征和/或胰岛素抵抗综合征),糖尿病,代谢性酸中毒,关节炎,白内障, 糖尿病性肾病,糖尿病性肾病,糖尿病性视网膜病变,糖尿病性心肌病,肥胖症,肥胖症,高血压,高脂血症,动脉粥样硬化,骨质疏松症,骨质减少症,虚弱,骨质疏松,骨折,急性冠状动脉综合征,生长激素缺乏引起的身材矮小,不育症 由于多囊卵巢综合征,焦虑症,抑郁症,失眠症,慢性疲劳,癫痫,进食障碍,慢性疼痛,酒精成瘾,与肠蠕动相关的疾病,溃疡,肠易激综合征,炎症性肠综合征; 短肠综合征 并预防2型糖尿病的疾病进展。
-
公开(公告)号:US20050154011A1
公开(公告)日:2005-07-14
申请号:US10633744
申请日:2003-08-04
申请人: Sean Klopfenstein , Matthew Maier , David Jones , Jeffrey Gray , Matthew Pokross , Kevin Peters , Artem Evdokimov
发明人: Sean Klopfenstein , Matthew Maier , David Jones , Jeffrey Gray , Matthew Pokross , Kevin Peters , Artem Evdokimov
IPC分类号: A61P3/10 , A61P43/00 , C07C307/02 , C07C311/19 , C07C311/27 , C07C311/51 , C07C311/53 , C07C323/41 , C07C323/60 , C07D207/16 , C07D211/62 , C07D213/82 , C07D231/40 , C07D233/38 , C07D295/13 , A61K31/4709 , C07D41/02
CPC分类号: C07D213/82 , C07C307/02 , C07C311/19 , C07C311/27 , C07C311/51 , C07C311/53 , C07C323/41 , C07C323/60 , C07C2601/08 , C07D207/16 , C07D211/62 , C07D231/40 , C07D233/38 , C07D295/13
摘要: Compounds of formula (I): are effective in the treatment of protein tyrosine phosphatase (PTPase) mediated disorder such as diabetes.
摘要翻译: 式(I)化合物:在治疗蛋白酪氨酸磷酸酶(PTPase)介导的病症如糖尿病中是有效的。
-
公开(公告)号:US20050153958A1
公开(公告)日:2005-07-14
申请号:US10506644
申请日:2003-02-21
申请人: Dorothee Hoischen , Stefan Herrmann , Kristian Kather , Klaus-Helmut Muller , Hans-Georg Schwarz , Otto Schallner , Mark Drewes , Peter Dahmen , Dieter Feucht , Rolf Pontzen
发明人: Dorothee Hoischen , Stefan Herrmann , Kristian Kather , Klaus-Helmut Muller , Hans-Georg Schwarz , Otto Schallner , Mark Drewes , Peter Dahmen , Dieter Feucht , Rolf Pontzen
IPC分类号: C07D233/38 , A01N33/24 , A01N35/06 , A01N41/06 , A01N41/10 , A01N43/08 , A01N43/10 , A01N43/40 , A01N43/50 , A01N43/56 , A01N43/78 , A01N57/28 , C07C239/20 , C07C243/26 , C07C281/04 , C07C311/04 , C07C311/17 , C07C317/24 , C07C317/48 , C07D213/42 , C07D213/55 , C07D213/81 , C07D231/20 , C07D233/80 , C07D277/28 , C07D307/12 , C07D307/14 , C07D307/52 , C07D309/04 , C07D309/06 , C07D309/20 , C07D333/34 , C07D335/02 , C07D401/12 , C07D403/12 , C07D405/12 , C07D409/12 , C07F9/24 , C07F9/6506 , A01N25/00 , A01N43/76
CPC分类号: A01N35/06 , A01N41/06 , A01N43/56 , C07C239/20 , C07C311/04 , C07C311/17 , C07C317/24 , C07C2601/02 , C07C2601/08 , C07C2601/14 , C07D213/55
摘要: The invention relates to novel aryl ketones of the formula (I) in which Z represents the groups and A1, A2, A3, R1, R2, R3, R4, R5, R6, R7, X, Y, and m are as defined in the disclosure, to their use as pesticides, in particular herbicides, and to processes and intermediates for their preparation.
摘要翻译: 本发明涉及式(I)的新型芳基酮,其中Z代表基团,A 1,A 2,A 3, R 1,R 2,R 3,R 4,R 5, R 6,R 7,X,Y和m如本公开所定义,用作农药,特别是除草剂,以及其用于 制备。
-
88.Catalytic depolymerization of polymers containing electrophilic linkages using nucleophilic reagents 有权
标题翻译: 使用亲核试剂催化解聚包含亲电键的聚合物公开(公告)号:US06911546B2
公开(公告)日:2005-06-28
申请号:US10330853
申请日:2002-12-26
IPC分类号: C07C59/285 , C07C67/03 , C07C68/06 , C07D233/02 , C07D233/04 , C07D233/06 , C07D233/16 , C07D233/54 , C07D307/33 , C07F1/00 , C07D233/38 , C07F2/46
CPC分类号: C07D233/16 , C07C59/285 , C07C67/03 , C07C68/06 , C07D233/02 , C07D233/04 , C07D233/06 , C07D233/54 , C07D307/33 , C07F1/00 , C07C69/82 , C07C69/96
摘要: A method is provided for carrying out depolymerization of a polymer containing electrophilic linkages in the presence of a catalyst and a nucleophilic reagent, wherein production of undesirable byproducts resulting from polymer degradation is minimized. The reaction can be carried out at a temperature of 80° C. or less, and generally involves the use of an organic, nonmetallic catalyst, thereby ensuring that the depolymerization product(s) are substantially free of metal contaminants. In an exemplary depolymerization method, the catalyst is a carbene compound such as an N-heterocyclic carbene, or is a precursor to a carbene compound. The method provides an important alternative to current recycling techniques such as those used in the degradation of polyesters, polyamides, and the like.
摘要翻译: 提供了一种在催化剂和亲核试剂的存在下进行含有亲电键的聚合物解聚的方法,其中由聚合物降解产生的不需要的副产物的产生最小化。 反应可以在80℃或更低的温度下进行,通常涉及使用有机非金属催化剂,从而确保解聚产物基本上不含金属污染物。 在示例性的解聚方法中,催化剂是卡宾化合物如N-杂环卡宾,或是卡宾化合物的前体。 该方法提供了当前回收技术的重要替代方法,例如用于降解聚酯,聚酰胺等的那些。
-
89.EPOTHILONE SYNTHESIS BUILDING BLOCKS III AND IV: ASYMMETRICALLY SUBSTITUTED ACYLOINS AND ACYLOIN DERIVATIVES, METHODS FOR THEIR PRODUCTION AND METHODS FOR THE PRODUCTION OF EPOTHILONES B, D AND EPOTHILONE DERIVATIVES 失效
标题翻译: EPOTHILONE SYNTHESIS建筑块III和IV:非对称取代的乙烯基和丙烯酸衍生物,其生产方法和生产苯乙烯B,D和EPOTHILONE衍生物的方法公开(公告)号:US06867333B2
公开(公告)日:2005-03-15
申请号:US10414510
申请日:2003-04-15
申请人: Ludger A. Wessjohann , Gunther Scheid , Uwe Bornscheuer , Erik Henke , Wouter Kuit , Romano Orru
发明人: Ludger A. Wessjohann , Gunther Scheid , Uwe Bornscheuer , Erik Henke , Wouter Kuit , Romano Orru
IPC分类号: C07C45/67 , C07C45/72 , C07C49/17 , C07C49/175 , C07C49/24 , C07C49/245 , C07C49/255 , C07C69/007 , C07C69/738 , C07D233/38 , C07D263/12 , C07D263/22 , C07D263/26 , C07D277/24 , C07D309/12 , C07D317/24 , C07D417/06 , C07D417/12 , C07D493/04 , C07F7/18 , C07C45/00 , C07C49/04
CPC分类号: C07D417/06 , C07B2200/07 , C07C45/673 , C07C45/72 , C07C49/17 , C07C49/175 , C07C49/24 , C07C49/245 , C07C49/255 , C07C69/007 , C07C69/738 , C07D233/38 , C07D263/12 , C07D263/22 , C07D263/26 , C07D277/24 , C07D309/12 , C07D317/24 , C07D417/12 , C07D493/04 , C07F7/1804
摘要: The present invention is directed to novel acyloins, their derivatives, methods for their production and their use for the production of novel epothilones and their derivatives. In addition, the invention is directed to the building blocks for epothilone synthesis, methods for their production and the use of synthetic building blocks for the production of epothilones and their derivatives.
摘要翻译: 本发明涉及新型偶联物,其衍生物,其制备方法及其用于生产新型埃坡霉素及其衍生物的用途。 此外,本发明涉及埃坡霉素合成的结构单元,其生产方法以及用于生产埃坡霉素及其衍生物的合成结构单元的使用。
-
90.Polyfunctional crosslinking agents and curable compositions containing the same 失效
标题翻译: 多官能交联剂和含有它们的可固化组合物公开(公告)号:US6028141A
公开(公告)日:2000-02-22
申请号:US881780
申请日:1997-06-24
IPC分类号: C07D233/40 , C08F8/30 , C08G71/02 , C08G73/02 , C08G73/06 , C08K5/3445 , C07D233/38 , C08F226/06 , C08G63/91
CPC分类号: C08G71/02 , C07D233/40 , C08F8/30 , C08G73/0273 , C08G73/0677 , C08K5/3445
摘要: Novel polyfunctonal glyoxylated compounds and compositions containing the same are disclosed which are particularly suitable for use as crosslinking components in curable compositions and also find use in imparting wet adhesion properties to water-based paints and coatings. A process for preparing novel polyfunctional glyoxylated compounds is also disclosed.
摘要翻译: 公开了新颖的多聚乙醛醛化合物和含有它们的组合物,其特别适合用作可固化组合物中的交联组分,并且还可用于赋予水性涂料和涂料湿粘合性能。 还公开了制备新型多官能乙醛化化合物的方法。
-
-
-
-
-
-
-
-
-